Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Treasury Shares: 2014-2024

Historic Treasury Shares for Catalyst Pharmaceuticals (CPRX) over the last 2 years, with Dec 2024 value amounting to $708,960.

  • Catalyst Pharmaceuticals' Treasury Shares fell 17.03% to $708,960 in Q4 2024 from the same period last year, while for Dec 2024 it was $708,960, marking a year-over-year decrease of 17.03%. This contributed to the annual value of $708,960 for FY2024, which is 17.03% down from last year.
  • Per Catalyst Pharmaceuticals' latest filing, its Treasury Shares stood at $708,960 for Q4 2024, which was down 17.03% from $854,459 recorded in Q4 2023.
  • Catalyst Pharmaceuticals' 5-year Treasury Shares high stood at $1.0 million for Q4 2022, and its period low was -$2.2 million during Q4 2021.
  • Over the past 3 years, Catalyst Pharmaceuticals' median Treasury Shares value was $154,480 (recorded in 2022), while the average stood at $93,903.
  • Per our database at Business Quant, Catalyst Pharmaceuticals' Treasury Shares tumbled by 1,037.02% in 2021 and then soared by 145.28% in 2022.
  • Over the past 5 years, Catalyst Pharmaceuticals' Treasury Shares (Quarterly) stood at $235,671 in 2020, then plummeted by 1,037.02% to -$2.2 million in 2021, then surged by 145.28% to $1.0 million in 2022, then fell by 14.55% to $854,459 in 2023, then decreased by 17.03% to $708,960 in 2024.
  • Its Treasury Shares stands at $708,960 for Q4 2024, versus $854,459 for Q4 2023 and $1.0 million for Q4 2022.